Skip to main content

Main menu

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • JRheum Supplements
  • Services

User menu

  • My Cart
  • Log In

Search

  • Advanced search
The Journal of Rheumatology
  • JRheum Supplements
  • Services
  • My Cart
  • Log In
The Journal of Rheumatology

Advanced Search

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • Follow jrheum on Twitter
  • Visit jrheum on Facebook
  • Follow jrheum on LinkedIn
  • Follow jrheum on YouTube
  • Follow jrheum on Instagram
  • Follow jrheum on RSS
Research ArticleArticle

Anti-DFS70/LEDGF Antibodies Are More Prevalent in Healthy Individuals Compared to Patients with Systemic Autoimmune Rheumatic Diseases

MICHAEL MAHLER, TODD PARKER, CAROL L. PEEBLES, LUIS E. ANDRADE, ANDREAS SWART, YVETTE CARBONE, DAVID J. FERGUSON, DANILO VILLALTA, NICOLA BIZZARO, JOHN G. HANLY and MARVIN J. FRITZLER
The Journal of Rheumatology November 2012, 39 (11) 2104-2110; DOI: https://doi.org/10.3899/jrheum.120598
MICHAEL MAHLER
From the Department of Research, Inova Diagnostics Inc., San Diego, California, USA; Fleury Medicine and Health Laboratory, Sao Paulo, SP, Brazil; Neuss Center for Rheumatology, Neuss, Germany; BC Biomedical Laboratories Ltd., Surrey, British Columbia, Canada; Department of Allergology and Clinical Immunology, AO S. Maria degli Angeli, Pordenone, Italy; Laboratory of Clinical Pathology, San Antonio Hospital, Tolmezzo, Italy; Faculty of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada; and Faculty of Medicine, University of Calgary, Calgary, Alberta, Canada.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: mmahler@inovadx.com m.mahler.job@web.de
TODD PARKER
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
CAROL L. PEEBLES
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
LUIS E. ANDRADE
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ANDREAS SWART
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
YVETTE CARBONE
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DAVID J. FERGUSON
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DANILO VILLALTA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
NICOLA BIZZARO
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
JOHN G. HANLY
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MARVIN J. FRITZLER
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • References
  • Info & Metrics
  • PDF
  • eLetters
PreviousNext
Loading

Published eLetters

eLetters are comments published online only and are not peer-reviewed. Publication of eLetter submissions is not guaranteed, and all submissions are reviewed and edited at the discretion of The Journal's staff.

If you wish to publish Letters to the Editor or Correspondence, please submit through our online submission system ScholarOne Manuscripts.

Submit a Response to This Article
Compose eLetter

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests

Vertical Tabs

Jump to comment:

No eLetters have been published for this article.
PreviousNext
Back to top

In this issue

The Journal of Rheumatology
Vol. 39, Issue 11
1 Nov 2012
  • Table of Contents
  • Table of Contents (PDF)
  • Index by Author
  • Editorial Board (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Rheumatology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Anti-DFS70/LEDGF Antibodies Are More Prevalent in Healthy Individuals Compared to Patients with Systemic Autoimmune Rheumatic Diseases
(Your Name) has forwarded a page to you from The Journal of Rheumatology
(Your Name) thought you would like to see this page from the The Journal of Rheumatology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Anti-DFS70/LEDGF Antibodies Are More Prevalent in Healthy Individuals Compared to Patients with Systemic Autoimmune Rheumatic Diseases
MICHAEL MAHLER, TODD PARKER, CAROL L. PEEBLES, LUIS E. ANDRADE, ANDREAS SWART, YVETTE CARBONE, DAVID J. FERGUSON, DANILO VILLALTA, NICOLA BIZZARO, JOHN G. HANLY, MARVIN J. FRITZLER
The Journal of Rheumatology Nov 2012, 39 (11) 2104-2110; DOI: 10.3899/jrheum.120598

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

 Request Permissions

Share
Anti-DFS70/LEDGF Antibodies Are More Prevalent in Healthy Individuals Compared to Patients with Systemic Autoimmune Rheumatic Diseases
MICHAEL MAHLER, TODD PARKER, CAROL L. PEEBLES, LUIS E. ANDRADE, ANDREAS SWART, YVETTE CARBONE, DAVID J. FERGUSON, DANILO VILLALTA, NICOLA BIZZARO, JOHN G. HANLY, MARVIN J. FRITZLER
The Journal of Rheumatology Nov 2012, 39 (11) 2104-2110; DOI: 10.3899/jrheum.120598
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • Acknowledgment
    • Footnotes
    • REFERENCES
  • Figures & Data
  • References
  • Info & Metrics
  • PDF
  • eLetters

Keywords

ANTINUCLEAR ANTIBODIES
DENSE FINE SPECKLES ANTIBODIES
LENS EPITHELIUM–DERIVED GROWTH FACTOR
AUTOANTIBODIES
SYSTEMIC LUPUS ERYTHEMATOSUS
AUTOIMMUNE DISEASE

Related Articles

Cited By...

More in this TOC Section

  • Vasculitis: What Have We Learned in the Last 50 Years?
  • Demographic, Lifestyle, and Serologic Risk Factors for Rheumatoid Arthritis (RA)–associated Bronchiectasis: Role of RA-related Autoantibodies
  • Effectiveness of 6-month Use of Secukinumab in Patients With Psoriatic Arthritis in the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry
Show more Article

Similar Articles

Keywords

  • ANTINUCLEAR ANTIBODIES
  • DENSE FINE SPECKLES ANTIBODIES
  • LENS EPITHELIUM–DERIVED GROWTH FACTOR
  • autoantibodies
  • systemic lupus erythematosus
  • autoimmune disease

Content

  • First Release
  • Current
  • Archives
  • Collections
  • Audiovisual Rheum
  • COVID-19 and Rheumatology

Resources

  • Guide for Authors
  • Submit Manuscript
  • Author Payment
  • Reviewers
  • Advertisers
  • Classified Ads
  • Reprints and Translations
  • Permissions
  • Meetings
  • FAQ
  • Policies

Subscribers

  • Subscription Information
  • Purchase Subscription
  • Your Account
  • Terms and Conditions

More

  • About Us
  • Contact Us
  • My Alerts
  • My Folders
  • Privacy/GDPR Policy
  • RSS Feeds
The Journal of Rheumatology
The content of this site is intended for health care professionals.
Copyright © 2022 by The Journal of Rheumatology Publishing Co. Ltd.
Print ISSN: 0315-162X; Online ISSN: 1499-2752
Powered by HighWire